NEWS

Company

偉喬生醫、生德奈、德國Cytena 攜手合作三方共創細胞株開發平台

May 17, 2024

Company

BICO Companies win Red Dot Design Award for Outstanding Product Design

March 31, 2022

威捷生物醫學創辦人林裕森(左一)、芯聖科技創辦人蔡孟燦(左二)、生德奈執行長蔡承翰(右二)。DIGITIMES

Company

「新創事業獎、中小企業創新研究獎暨小巨人獎」11/22盛大頒獎

November 25, 2021

Company

CYTENA BIOPROCESS SOLUTIONS Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals

October 6, 2021

Company

CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows

July 19, 2021

Keep up with the latest technology by signing up

By entering your email, you agree to our Terms of Service and Privacy Statement

CONTACT US

+886 2 2720 6135

North Design Industry Building 13F., No. 22, Sec. 3, Zhongshan N. Rd., Zhongshan Dist. 104427 - Taipei Taiwan

Report A Cyber Security Incident

NAVIGATION

CODE OF CONDUCT

Whistleblower/speak up channel

CYTENA BPS is a part of BICO. Our products aim to reduce the organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology, fundamentally shifting the global healthcare industry.

Read more at BICO.com

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

News

偉喬生醫、生德奈、德國Cytena 攜手合作三方共創細胞株開發平台

BICO Companies win Red Dot Design Award for Outstanding Product Design

醫療產業注入新活水台灣生醫新創於D talk展現AI數位力

「新創事業獎、中小企業創新研究獎暨小巨人獎」11/22盛大頒獎

CYTENA BIOPROCESS SOLUTIONS Closes $5M Funding to Develop Automatic High-throughput Screening Platform for Pharmaceuticals

CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows

Keep up with the latest technology by signing up

CONTACT US

+886 2 2720 6135

info@cytena-bps.com

North Design Industry Building 13F., No. 22, Sec. 3, Zhongshan N. Rd., Zhongshan Dist. 104427 - Taipei Taiwan

Report A Cyber Security Incident

NAVIGATION

Our story

News

S.NEST® 2.0

C.NEST®

C.BIRD™

Consumables

CODE OF CONDUCT

Supplier Code of Conduct

Internal Code of Conduct

Whistleblower/speak up channel

COPYRIGHT © 2025 Cytena Bioprocess Solutions - All rights reserved.